Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

A systematic review of randomized controlled trials (RCTs) assessed the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for obesity in adults without ...

For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral neuropathy, especially in the hands and feet, is a common side effect.

New use of gabapentin (Neurontin) was not associated with greater risk of falls in older adults with neuropathy or ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.00 and ...

Under the partnership, the companies say they will offer clients more relevant and functional assays for drug development.

NMD Pharma Announces FDA Orphan Drug Designation Granted to NMD670 for the Treatment of Patients with Charcot-Marie-Tooth Disease This is the 2nd ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

KLS-2031 is under clinical development by Kolon Life Science and currently in Phase II for Radiculopathy. According to GlobalData, Phase II drugs for Radiculopathy does not have sufficient historical ...

Obudanersen sodium is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Angelman Syndrome.